ENANTA PHARMACEUTICALS INC Annual General and Administrative Expense in USD from 2011 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
Summary
Enanta Pharmaceuticals Inc quarterly/annual General and Administrative Expense history and growth rate from 2011 to 2023.
  • Enanta Pharmaceuticals Inc General and Administrative Expense for the quarter ending June 30, 2024 was $13.4M, a 6.31% increase year-over-year.
  • Enanta Pharmaceuticals Inc General and Administrative Expense for the twelve months ending June 30, 2024 was $58M, a 12.2% increase year-over-year.
  • Enanta Pharmaceuticals Inc annual General and Administrative Expense for 2023 was $52.9M, a 16.3% increase from 2022.
  • Enanta Pharmaceuticals Inc annual General and Administrative Expense for 2022 was $45.5M, a 39.8% increase from 2021.
  • Enanta Pharmaceuticals Inc annual General and Administrative Expense for 2021 was $32.5M, a 18.9% increase from 2020.
General and Administrative Expense, Trailing 12 Months (USD)
General and Administrative Expense, Annual (USD)
General and Administrative Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $52.9M +$7.41M +16.3% Oct 1, 2022 Sep 30, 2023 10-K 2023-11-22
2022 $45.5M +$12.9M +39.8% Oct 1, 2021 Sep 30, 2022 10-K 2023-11-22
2021 $32.5M +$5.18M +18.9% Oct 1, 2020 Sep 30, 2021 10-K 2023-11-22
2020 $27.4M +$1.11M +4.23% Oct 1, 2019 Sep 30, 2020 10-K 2022-11-23
2019 $26.2M +$2.81M +12% Oct 1, 2018 Sep 30, 2019 10-K 2021-11-24
2018 $23.4M +$2.69M +13% Oct 1, 2017 Sep 30, 2018 10-K 2020-11-25
2017 $20.7M +$3.78M +22.3% Oct 1, 2016 Sep 30, 2017 10-K 2019-11-27
2016 $17M +$3.42M +25.3% Oct 1, 2015 Sep 30, 2016 10-K 2018-11-29
2015 $13.5M +$3.53M +35.2% Oct 1, 2014 Sep 30, 2015 10-K 2017-12-11
2014 $10M +$3.83M +62% Oct 1, 2013 Sep 30, 2014 10-K 2016-12-09
2013 $6.18M +$881K +16.6% Oct 1, 2012 Sep 30, 2013 10-K 2015-12-11
2012 $5.3M +$266K +5.28% Oct 1, 2011 Sep 30, 2012 10-K 2014-12-11
2011 $5.04M Oct 1, 2010 Sep 30, 2011 10-K 2013-12-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.